Homoisopogon A

ID: ALA4210154

PubChem CID: 145965921

Max Phase: Preclinical

Molecular Formula: C19H20O6

Molecular Weight: 344.36

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(C[C@@H]2COc3cc(OC)c(C)c(O)c3C2=O)c(O)c1

Standard InChI:  InChI=1S/C19H20O6/c1-10-15(24-3)8-16-17(18(10)21)19(22)12(9-25-16)6-11-4-5-13(23-2)7-14(11)20/h4-5,7-8,12,20-21H,6,9H2,1-3H3/t12-/m1/s1

Standard InChI Key:  CSRHPQPWJUWOAK-GFCCVEGCSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
    4.5963  -25.5970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5952  -26.4166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3032  -26.8255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3014  -25.1882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0100  -25.5934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0089  -26.4141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7151  -26.8231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4270  -26.4161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4281  -25.5954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7174  -25.1818    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1335  -26.8266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8424  -26.4200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5461  -26.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2545  -26.4284    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2572  -25.6103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5457  -25.1999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8402  -25.6082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7128  -27.6403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8885  -25.1886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8883  -24.3714    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9655  -25.2027    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6726  -25.6124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8871  -26.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3049  -27.6427    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5414  -27.6515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  1
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  7 18  2  0
  1 19  1  0
 19 20  1  0
 15 21  1  0
 21 22  1  0
  2 23  1  0
  3 24  1  0
 13 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4210154

    ---

Associated Targets(Human)

SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lu1 (576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.36Molecular Weight (Monoisotopic): 344.1260AlogP: 2.86#Rotatable Bonds: 4
Polar Surface Area: 85.22Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.88CX Basic pKa: CX LogP: 3.67CX LogD: 3.66
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.89Np Likeness Score: 1.58

References

1. Simon L, Abdul Salam AA, Madan Kumar S, Shilpa T, Srinivasan KK, Byrappa K..  (2017)  Synthesis, anticancer, structural, and computational docking studies of 3-benzylchroman-4-one derivatives.,  27  (23): [PMID:29074256] [10.1016/j.bmcl.2017.10.026]

Source